| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Germ Cells | 7 | 2023 | 631 | 2.770 |
Why?
|
| Induced Pluripotent Stem Cells | 8 | 2023 | 1736 | 1.610 |
Why?
|
| Estrogens | 10 | 2021 | 1566 | 1.500 |
Why?
|
| Embryoid Bodies | 4 | 2021 | 67 | 1.460 |
Why?
|
| Endocrine Disruptors | 8 | 2021 | 237 | 1.380 |
Why?
|
| Epigenesis, Genetic | 10 | 2021 | 3647 | 1.050 |
Why?
|
| DNA Methylation | 14 | 2021 | 4286 | 1.020 |
Why?
|
| Sex Determination Processes | 3 | 2021 | 58 | 0.960 |
Why?
|
| Germ Layers | 2 | 2022 | 73 | 0.960 |
Why?
|
| Chick Embryo | 10 | 2021 | 982 | 0.940 |
Why?
|
| Phenols | 7 | 2018 | 497 | 0.920 |
Why?
|
| Feminization | 2 | 2021 | 23 | 0.880 |
Why?
|
| Trans-Activators | 22 | 2010 | 2924 | 0.870 |
Why?
|
| Promoter Regions, Genetic | 17 | 2018 | 5867 | 0.860 |
Why?
|
| Estradiol | 9 | 2013 | 2020 | 0.850 |
Why?
|
| Chickens | 3 | 2021 | 865 | 0.850 |
Why?
|
| Benzhydryl Compounds | 7 | 2018 | 845 | 0.780 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2021 | 3617 | 0.770 |
Why?
|
| Gastrula | 1 | 2021 | 84 | 0.760 |
Why?
|
| Testis | 3 | 2022 | 803 | 0.710 |
Why?
|
| Nuclear Proteins | 23 | 2011 | 5853 | 0.710 |
Why?
|
| Genomic Imprinting | 5 | 2017 | 328 | 0.700 |
Why?
|
| Fluorocarbons | 1 | 2023 | 452 | 0.650 |
Why?
|
| Neoplastic Cells, Circulating | 8 | 2018 | 934 | 0.650 |
Why?
|
| Folic Acid Deficiency | 1 | 2019 | 115 | 0.640 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2023 | 501 | 0.640 |
Why?
|
| Sulfites | 1 | 2018 | 79 | 0.620 |
Why?
|
| Body Patterning | 2 | 2019 | 626 | 0.610 |
Why?
|
| Cell Culture Techniques | 4 | 2021 | 1678 | 0.610 |
Why?
|
| Testicular Neoplasms | 1 | 2023 | 804 | 0.600 |
Why?
|
| Lentivirus | 3 | 2011 | 501 | 0.590 |
Why?
|
| Estrogen Receptor Modulators | 2 | 2009 | 61 | 0.590 |
Why?
|
| Phosphotransferases | 1 | 2018 | 308 | 0.580 |
Why?
|
| Apoptosis Regulatory Proteins | 18 | 2010 | 1157 | 0.560 |
Why?
|
| Prenatal Exposure Delayed Effects | 7 | 2023 | 2408 | 0.550 |
Why?
|
| Immunophenotyping | 1 | 2021 | 1880 | 0.540 |
Why?
|
| Mammary Glands, Animal | 5 | 2014 | 276 | 0.530 |
Why?
|
| Estrogen Receptor alpha | 5 | 2014 | 577 | 0.500 |
Why?
|
| Pluripotent Stem Cells | 3 | 2017 | 795 | 0.490 |
Why?
|
| Gene Expression Profiling | 18 | 2019 | 9438 | 0.480 |
Why?
|
| Transcription Factors | 16 | 2023 | 12208 | 0.470 |
Why?
|
| HIV-1 | 19 | 2007 | 6939 | 0.460 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2013 | 1338 | 0.460 |
Why?
|
| Polymorphism, Genetic | 5 | 2013 | 4328 | 0.460 |
Why?
|
| Transcriptional Activation | 11 | 2018 | 1783 | 0.460 |
Why?
|
| Virus Cultivation | 3 | 2011 | 92 | 0.440 |
Why?
|
| Gene Expression Regulation, Neoplastic | 13 | 2017 | 8428 | 0.440 |
Why?
|
| Epigenomics | 2 | 2018 | 903 | 0.430 |
Why?
|
| Estrogen Antagonists | 1 | 2013 | 152 | 0.430 |
Why?
|
| DNA, Mitochondrial | 1 | 2018 | 817 | 0.430 |
Why?
|
| RNA, Messenger | 25 | 2014 | 13033 | 0.430 |
Why?
|
| Fetal Blood | 1 | 2019 | 1318 | 0.430 |
Why?
|
| Avian Proteins | 1 | 2012 | 80 | 0.420 |
Why?
|
| Aromatase | 1 | 2012 | 146 | 0.410 |
Why?
|
| Sequence Analysis, DNA | 5 | 2018 | 4803 | 0.410 |
Why?
|
| Cell Differentiation | 15 | 2023 | 11483 | 0.390 |
Why?
|
| Respirovirus | 11 | 2000 | 31 | 0.390 |
Why?
|
| Animals | 95 | 2023 | 168757 | 0.380 |
Why?
|
| Virology | 1 | 2011 | 77 | 0.380 |
Why?
|
| Sex Determination Analysis | 1 | 2010 | 44 | 0.380 |
Why?
|
| Drug Resistance, Neoplasm | 10 | 2018 | 5172 | 0.380 |
Why?
|
| Gene Expression Regulation | 15 | 2019 | 12072 | 0.370 |
Why?
|
| Trialkyltin Compounds | 3 | 2018 | 6 | 0.370 |
Why?
|
| src-Family Kinases | 1 | 2013 | 551 | 0.360 |
Why?
|
| Retinoid X Receptors | 3 | 2019 | 93 | 0.360 |
Why?
|
| Sex Chromosomes | 1 | 2010 | 105 | 0.360 |
Why?
|
| Base Sequence | 30 | 2007 | 12797 | 0.350 |
Why?
|
| Immunohistochemistry | 6 | 2021 | 11366 | 0.330 |
Why?
|
| Virus Assembly | 2 | 2009 | 144 | 0.330 |
Why?
|
| Membrane Proteins | 7 | 2016 | 7880 | 0.330 |
Why?
|
| Adipogenesis | 4 | 2023 | 359 | 0.330 |
Why?
|
| Octamer Transcription Factor-3 | 3 | 2019 | 223 | 0.320 |
Why?
|
| Mesoderm | 4 | 2018 | 686 | 0.320 |
Why?
|
| Chemokines, CXC | 7 | 2003 | 422 | 0.320 |
Why?
|
| Receptors, Progesterone | 4 | 2016 | 1097 | 0.320 |
Why?
|
| Apoptosis | 7 | 2014 | 9727 | 0.320 |
Why?
|
| Single-Cell Analysis | 7 | 2022 | 2183 | 0.310 |
Why?
|
| Genome | 1 | 2016 | 1808 | 0.310 |
Why?
|
| CpG Islands | 3 | 2018 | 1172 | 0.310 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 9 | 2014 | 3920 | 0.310 |
Why?
|
| Untranslated Regions | 1 | 2007 | 31 | 0.300 |
Why?
|
| Mice | 57 | 2023 | 81183 | 0.300 |
Why?
|
| Codon, Initiator | 1 | 2007 | 52 | 0.300 |
Why?
|
| Sex Differentiation | 2 | 2021 | 73 | 0.300 |
Why?
|
| Breast Neoplasms | 18 | 2018 | 20822 | 0.290 |
Why?
|
| Cells, Cultured | 14 | 2022 | 19229 | 0.290 |
Why?
|
| Trinucleotide Repeat Expansion | 3 | 2014 | 243 | 0.280 |
Why?
|
| Gene Expression | 10 | 2017 | 7799 | 0.280 |
Why?
|
| Interleukin-7 | 1 | 2007 | 142 | 0.280 |
Why?
|
| Cell Movement | 3 | 2017 | 5217 | 0.280 |
Why?
|
| Benzo(a)pyrene | 2 | 2023 | 26 | 0.270 |
Why?
|
| Melanoma, Experimental | 3 | 2001 | 561 | 0.270 |
Why?
|
| COS Cells | 6 | 2011 | 1161 | 0.260 |
Why?
|
| Huntington Disease | 4 | 2014 | 1124 | 0.260 |
Why?
|
| DNA-Binding Proteins | 9 | 2017 | 9648 | 0.260 |
Why?
|
| Molecular Sequence Data | 24 | 2007 | 18111 | 0.260 |
Why?
|
| Embryo, Mammalian | 4 | 2022 | 1701 | 0.260 |
Why?
|
| Transcription, Genetic | 23 | 2016 | 7722 | 0.260 |
Why?
|
| Obesity | 7 | 2023 | 12745 | 0.260 |
Why?
|
| Chemokine CXCL12 | 8 | 2017 | 464 | 0.260 |
Why?
|
| Receptors, CCR5 | 1 | 2007 | 497 | 0.260 |
Why?
|
| Keratins | 3 | 2022 | 515 | 0.260 |
Why?
|
| Transfection | 11 | 2016 | 5892 | 0.260 |
Why?
|
| Embryonic Stem Cells | 4 | 2018 | 1294 | 0.250 |
Why?
|
| Mesenchymal Stem Cells | 3 | 2023 | 1632 | 0.250 |
Why?
|
| MAP Kinase Kinase Kinases | 2 | 2018 | 261 | 0.240 |
Why?
|
| Toxicogenetics | 1 | 2004 | 31 | 0.240 |
Why?
|
| Cell Line | 29 | 2013 | 15997 | 0.230 |
Why?
|
| Polymerase Chain Reaction | 11 | 2018 | 6171 | 0.230 |
Why?
|
| Epithelial Cells | 3 | 2017 | 3690 | 0.230 |
Why?
|
| Cell Line, Tumor | 18 | 2019 | 16689 | 0.230 |
Why?
|
| Genes, Reporter | 4 | 2007 | 1547 | 0.230 |
Why?
|
| Acquired Immunodeficiency Syndrome | 6 | 2007 | 2232 | 0.220 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2019 | 670 | 0.220 |
Why?
|
| HIV Envelope Protein gp120 | 4 | 1997 | 952 | 0.220 |
Why?
|
| Gametogenesis | 1 | 2023 | 26 | 0.220 |
Why?
|
| Tumor Cells, Cultured | 14 | 2014 | 6314 | 0.220 |
Why?
|
| Genes, Viral | 8 | 1999 | 718 | 0.220 |
Why?
|
| Giant Cells | 4 | 2000 | 187 | 0.220 |
Why?
|
| Humans | 102 | 2023 | 744343 | 0.220 |
Why?
|
| Reference Standards | 1 | 2006 | 1025 | 0.210 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 3 | 2011 | 137 | 0.210 |
Why?
|
| Cloning, Molecular | 15 | 2002 | 4320 | 0.210 |
Why?
|
| Inheritance Patterns | 2 | 2021 | 340 | 0.210 |
Why?
|
| Chemokine CCL5 | 2 | 2000 | 209 | 0.210 |
Why?
|
| Gonads | 1 | 2022 | 109 | 0.200 |
Why?
|
| Dipeptidyl Peptidase 4 | 2 | 1998 | 91 | 0.200 |
Why?
|
| Repressor Proteins | 4 | 2017 | 3023 | 0.200 |
Why?
|
| Pregnancy, Animal | 1 | 2022 | 134 | 0.200 |
Why?
|
| Ovary | 4 | 2023 | 981 | 0.190 |
Why?
|
| Antineoplastic Agents, Hormonal | 3 | 2018 | 1524 | 0.190 |
Why?
|
| Adipocytes | 2 | 2018 | 1184 | 0.190 |
Why?
|
| Melanocytes | 3 | 2001 | 515 | 0.190 |
Why?
|
| Introns | 4 | 2013 | 991 | 0.190 |
Why?
|
| Protein Biosynthesis | 5 | 2007 | 2126 | 0.190 |
Why?
|
| Reassortant Viruses | 1 | 2000 | 37 | 0.190 |
Why?
|
| MicroRNAs | 5 | 2023 | 3752 | 0.190 |
Why?
|
| Amino Acid Sequence | 24 | 2002 | 13815 | 0.190 |
Why?
|
| Sequence Homology, Amino Acid | 10 | 2002 | 2839 | 0.190 |
Why?
|
| Gene Regulatory Networks | 1 | 2009 | 1708 | 0.190 |
Why?
|
| Oryzias | 1 | 2000 | 19 | 0.180 |
Why?
|
| Baculoviridae | 1 | 2000 | 118 | 0.180 |
Why?
|
| Receptors, Androgen | 2 | 2018 | 1058 | 0.180 |
Why?
|
| Calcium-Binding Proteins | 4 | 2016 | 1081 | 0.180 |
Why?
|
| Virus Replication | 13 | 2009 | 2534 | 0.180 |
Why?
|
| RNA, Neoplasm | 3 | 2006 | 769 | 0.180 |
Why?
|
| beta-Galactosidase | 2 | 2000 | 573 | 0.180 |
Why?
|
| Parainfluenza Virus 1, Human | 4 | 1995 | 28 | 0.180 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 5 | 2016 | 1676 | 0.180 |
Why?
|
| Female | 48 | 2023 | 380194 | 0.180 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2000 | 54 | 0.180 |
Why?
|
| Mammals | 2 | 2023 | 1143 | 0.180 |
Why?
|
| Chromatin | 4 | 2021 | 2934 | 0.180 |
Why?
|
| Smad4 Protein | 5 | 2006 | 163 | 0.170 |
Why?
|
| Tamoxifen | 4 | 2013 | 981 | 0.170 |
Why?
|
| Interleukin-4 | 2 | 2000 | 1147 | 0.170 |
Why?
|
| X Chromosome | 3 | 2004 | 814 | 0.170 |
Why?
|
| Viral Proteins | 7 | 2001 | 1900 | 0.170 |
Why?
|
| Protein Kinase Inhibitors | 6 | 2018 | 5535 | 0.170 |
Why?
|
| Mitosis | 3 | 2019 | 1208 | 0.170 |
Why?
|
| Plasmids | 6 | 2001 | 2307 | 0.170 |
Why?
|
| RNA, Viral | 9 | 2001 | 2902 | 0.170 |
Why?
|
| Transcription Factor AP-2 | 2 | 2017 | 82 | 0.160 |
Why?
|
| Receptors, CXCR4 | 3 | 2017 | 726 | 0.160 |
Why?
|
| 5-Methylcytosine | 2 | 2016 | 154 | 0.160 |
Why?
|
| Adipose Tissue, White | 2 | 2018 | 351 | 0.160 |
Why?
|
| Male | 34 | 2023 | 350118 | 0.160 |
Why?
|
| Stromal Cells | 3 | 2019 | 1355 | 0.160 |
Why?
|
| DNA Primers | 10 | 2007 | 2892 | 0.160 |
Why?
|
| SOXF Transcription Factors | 1 | 2017 | 29 | 0.160 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2018 | 232 | 0.150 |
Why?
|
| Pregnancy | 12 | 2023 | 29144 | 0.150 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2000 | 404 | 0.150 |
Why?
|
| Gene Products, env | 2 | 1998 | 263 | 0.150 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2015 | 2948 | 0.150 |
Why?
|
| MAP Kinase Kinase 1 | 2 | 2017 | 337 | 0.150 |
Why?
|
| Cell Aggregation | 1 | 2017 | 244 | 0.150 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2017 | 96 | 0.150 |
Why?
|
| Body Weight | 2 | 2018 | 4669 | 0.150 |
Why?
|
| Luminescent Proteins | 1 | 2000 | 853 | 0.150 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2019 | 3597 | 0.150 |
Why?
|
| Cyclopropanes | 1 | 2018 | 416 | 0.150 |
Why?
|
| Prolactin | 1 | 2019 | 669 | 0.140 |
Why?
|
| Luciferases | 4 | 2007 | 733 | 0.140 |
Why?
|
| Carbohydrate Metabolism | 1 | 2018 | 264 | 0.140 |
Why?
|
| Cytosine | 1 | 2018 | 216 | 0.140 |
Why?
|
| Nerve Tissue Proteins | 4 | 2014 | 4462 | 0.140 |
Why?
|
| Cell Separation | 3 | 2017 | 1751 | 0.140 |
Why?
|
| Genes, Homeobox | 1 | 2017 | 286 | 0.140 |
Why?
|
| Mitochondrial Proteins | 3 | 2009 | 996 | 0.140 |
Why?
|
| Neoplasm Metastasis | 3 | 2014 | 4851 | 0.140 |
Why?
|
| Genome-Wide Association Study | 3 | 2018 | 12261 | 0.140 |
Why?
|
| Genetic Vectors | 4 | 2000 | 3420 | 0.140 |
Why?
|
| Placenta | 2 | 2022 | 1698 | 0.140 |
Why?
|
| Gene Frequency | 4 | 2014 | 3588 | 0.140 |
Why?
|
| Chromosome Mapping | 2 | 2009 | 4740 | 0.140 |
Why?
|
| Sequence Analysis, RNA | 7 | 2018 | 2012 | 0.140 |
Why?
|
| Environmental Exposure | 4 | 2021 | 4234 | 0.140 |
Why?
|
| Cardiac Tamponade | 1 | 1997 | 173 | 0.130 |
Why?
|
| Genomic Instability | 2 | 2018 | 695 | 0.130 |
Why?
|
| Parainfluenza Virus 3, Human | 4 | 1988 | 24 | 0.130 |
Why?
|
| Neoplastic Stem Cells | 2 | 2021 | 1376 | 0.130 |
Why?
|
| Sequence Homology, Nucleic Acid | 8 | 2002 | 1085 | 0.130 |
Why?
|
| Cell Cycle | 3 | 2015 | 2967 | 0.130 |
Why?
|
| Prostate | 4 | 2017 | 1774 | 0.130 |
Why?
|
| Ethinyl Estradiol | 2 | 2013 | 116 | 0.130 |
Why?
|
| Blotting, Western | 8 | 2014 | 5179 | 0.130 |
Why?
|
| Reproduction | 1 | 2000 | 668 | 0.130 |
Why?
|
| Receptors, Estrogen | 4 | 2017 | 2187 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2015 | 66 | 0.130 |
Why?
|
| bcl-X Protein | 2 | 2015 | 411 | 0.130 |
Why?
|
| Fibrosarcoma | 1 | 1997 | 348 | 0.120 |
Why?
|
| Iodide Peroxidase | 1 | 2016 | 293 | 0.120 |
Why?
|
| Xenopus laevis | 1 | 2018 | 957 | 0.120 |
Why?
|
| Glucose Intolerance | 1 | 2018 | 577 | 0.120 |
Why?
|
| DNA, Complementary | 6 | 2002 | 2050 | 0.120 |
Why?
|
| Japan | 3 | 2007 | 1360 | 0.120 |
Why?
|
| Microarray Analysis | 3 | 2013 | 767 | 0.120 |
Why?
|
| Phenylthiohydantoin | 1 | 2015 | 193 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2013 | 10943 | 0.120 |
Why?
|
| Protein Kinase C | 2 | 1998 | 1227 | 0.120 |
Why?
|
| Recombinant Fusion Proteins | 7 | 2007 | 3772 | 0.120 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 2 | 2010 | 52 | 0.110 |
Why?
|
| Genetic Variation | 5 | 1997 | 6544 | 0.110 |
Why?
|
| RNA Interference | 5 | 2014 | 2889 | 0.110 |
Why?
|
| Prostatic Neoplasms | 5 | 2021 | 11124 | 0.110 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2007 | 768 | 0.110 |
Why?
|
| Heart Neoplasms | 1 | 1997 | 374 | 0.110 |
Why?
|
| Chemokines | 1 | 2017 | 970 | 0.110 |
Why?
|
| E1A-Associated p300 Protein | 3 | 2002 | 131 | 0.110 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 1994 | 440 | 0.110 |
Why?
|
| Wnt Proteins | 2 | 2015 | 721 | 0.110 |
Why?
|
| Stem Cell Niche | 1 | 2016 | 346 | 0.110 |
Why?
|
| Carrier Proteins | 5 | 2014 | 5021 | 0.110 |
Why?
|
| Transforming Growth Factor alpha | 2 | 2003 | 135 | 0.110 |
Why?
|
| Immediate-Early Proteins | 1 | 2015 | 453 | 0.110 |
Why?
|
| PPAR gamma | 3 | 2023 | 493 | 0.110 |
Why?
|
| Gestational Age | 2 | 2019 | 3493 | 0.110 |
Why?
|
| Microcirculation | 1 | 1997 | 1286 | 0.110 |
Why?
|
| RNA | 2 | 2021 | 2749 | 0.110 |
Why?
|
| Antineoplastic Agents | 6 | 2015 | 13695 | 0.110 |
Why?
|
| HIV Infections | 4 | 2000 | 16718 | 0.110 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2013 | 271 | 0.100 |
Why?
|
| Epithelium | 3 | 2013 | 1679 | 0.100 |
Why?
|
| Trinucleotide Repeats | 1 | 2013 | 261 | 0.100 |
Why?
|
| Stress, Physiological | 1 | 2019 | 1403 | 0.100 |
Why?
|
| DNA | 9 | 2010 | 7301 | 0.100 |
Why?
|
| Disorders of Sex Development | 1 | 2012 | 122 | 0.100 |
Why?
|
| Tetradecanoylphorbol Acetate | 3 | 1998 | 821 | 0.100 |
Why?
|
| Aniline Compounds | 2 | 2015 | 986 | 0.100 |
Why?
|
| Kidney | 6 | 2007 | 7186 | 0.100 |
Why?
|
| Embryonic and Fetal Development | 2 | 2004 | 438 | 0.100 |
Why?
|
| Blotting, Northern | 4 | 2002 | 1581 | 0.100 |
Why?
|
| Retinoblastoma Protein | 1 | 2015 | 704 | 0.100 |
Why?
|
| Sex Characteristics | 2 | 2021 | 2585 | 0.100 |
Why?
|
| Cell Lineage | 3 | 2022 | 2504 | 0.100 |
Why?
|
| Genes | 5 | 2002 | 1893 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 11 | 2023 | 21827 | 0.100 |
Why?
|
| Protein Binding | 8 | 2017 | 9386 | 0.100 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 1 | 2010 | 27 | 0.090 |
Why?
|
| Computational Biology | 2 | 2022 | 3521 | 0.090 |
Why?
|
| Mice, Inbred NOD | 4 | 2016 | 1878 | 0.090 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2011 | 258 | 0.090 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2015 | 388 | 0.090 |
Why?
|
| Membrane Glycoproteins | 3 | 2016 | 3768 | 0.090 |
Why?
|
| Neostriatum | 1 | 2011 | 250 | 0.090 |
Why?
|
| Signal Transduction | 11 | 2019 | 23403 | 0.090 |
Why?
|
| T-Lymphocytes | 6 | 1998 | 10180 | 0.090 |
Why?
|
| YY1 Transcription Factor | 1 | 2010 | 60 | 0.090 |
Why?
|
| RNA, Small Interfering | 5 | 2015 | 3505 | 0.090 |
Why?
|
| Neoplastic Processes | 1 | 2009 | 35 | 0.090 |
Why?
|
| Benzimidazoles | 2 | 2012 | 850 | 0.090 |
Why?
|
| Chromosomes, Mammalian | 1 | 2010 | 151 | 0.090 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2011 | 322 | 0.090 |
Why?
|
| Neuraminidase | 3 | 1998 | 210 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 1999 | 4386 | 0.090 |
Why?
|
| Weight Gain | 2 | 2018 | 2292 | 0.090 |
Why?
|
| Point Mutation | 1 | 1994 | 1623 | 0.080 |
Why?
|
| Homeodomain Proteins | 2 | 2009 | 2421 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2019 | 2849 | 0.080 |
Why?
|
| Sirtuin 1 | 1 | 2010 | 246 | 0.080 |
Why?
|
| Fetus | 2 | 2013 | 1880 | 0.080 |
Why?
|
| Unfolded Protein Response | 1 | 2011 | 233 | 0.080 |
Why?
|
| Mutation | 9 | 2017 | 29786 | 0.080 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1998 | 1888 | 0.080 |
Why?
|
| Viral Envelope Proteins | 3 | 1998 | 635 | 0.080 |
Why?
|
| Disease Progression | 7 | 2015 | 13284 | 0.080 |
Why?
|
| Viral Fusion Proteins | 3 | 1999 | 95 | 0.080 |
Why?
|
| Ascorbic Acid | 1 | 2012 | 651 | 0.080 |
Why?
|
| Phylogeny | 4 | 2007 | 2803 | 0.080 |
Why?
|
| RNA-Binding Proteins | 1 | 2017 | 1903 | 0.080 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2015 | 828 | 0.080 |
Why?
|
| Choline Dehydrogenase | 1 | 2007 | 4 | 0.080 |
Why?
|
| Melanoma | 3 | 2008 | 5510 | 0.080 |
Why?
|
| Alleles | 4 | 2013 | 6933 | 0.080 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2010 | 514 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2011 | 2505 | 0.080 |
Why?
|
| DNA, Viral | 7 | 1998 | 2225 | 0.080 |
Why?
|
| Cell Survival | 4 | 2016 | 5882 | 0.080 |
Why?
|
| Haplotypes | 2 | 2007 | 2779 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2008 | 203 | 0.080 |
Why?
|
| Cell Adhesion | 2 | 2018 | 3144 | 0.080 |
Why?
|
| Cerebellum | 2 | 2013 | 1488 | 0.080 |
Why?
|
| Methylation | 2 | 2021 | 1106 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 3 | 2017 | 1655 | 0.080 |
Why?
|
| Clone Cells | 2 | 2009 | 1692 | 0.080 |
Why?
|
| Sequence Alignment | 3 | 2002 | 2256 | 0.070 |
Why?
|
| Decidua | 1 | 2007 | 86 | 0.070 |
Why?
|
| Blastocyst | 2 | 2022 | 424 | 0.070 |
Why?
|
| Databases, Genetic | 1 | 2014 | 1783 | 0.070 |
Why?
|
| Retinal Dehydrogenase | 2 | 2018 | 74 | 0.070 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2010 | 560 | 0.070 |
Why?
|
| Leupeptins | 1 | 2006 | 122 | 0.070 |
Why?
|
| Sulfonamides | 2 | 2015 | 1938 | 0.070 |
Why?
|
| Bacterial Proteins | 1 | 2000 | 3848 | 0.070 |
Why?
|
| Androgen Antagonists | 1 | 2015 | 1377 | 0.070 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 1741 | 0.070 |
Why?
|
| Receptors, Vasopressin | 1 | 2007 | 112 | 0.070 |
Why?
|
| Cell Proliferation | 3 | 2014 | 10481 | 0.070 |
Why?
|
| Phenotype | 4 | 2021 | 16365 | 0.070 |
Why?
|
| Mice, Nude | 4 | 2016 | 3689 | 0.070 |
Why?
|
| Receptors, Interleukin | 1 | 2007 | 245 | 0.070 |
Why?
|
| Cytokines | 2 | 1998 | 7322 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2016 | 3386 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2023 | 21746 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2015 | 3557 | 0.070 |
Why?
|
| Genetic Markers | 1 | 2012 | 2634 | 0.070 |
Why?
|
| Binding Sites | 3 | 2000 | 6114 | 0.070 |
Why?
|
| Morphogenesis | 2 | 2007 | 752 | 0.070 |
Why?
|
| Paclitaxel | 1 | 2013 | 1708 | 0.070 |
Why?
|
| Exons | 3 | 2002 | 2437 | 0.070 |
Why?
|
| Caenorhabditis elegans | 2 | 2011 | 1419 | 0.070 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2006 | 147 | 0.070 |
Why?
|
| Bone Neoplasms | 1 | 2018 | 2529 | 0.070 |
Why?
|
| Up-Regulation | 4 | 2019 | 4217 | 0.070 |
Why?
|
| Gamma Rays | 1 | 2006 | 320 | 0.060 |
Why?
|
| Mice, SCID | 3 | 2016 | 2716 | 0.060 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 1692 | 0.060 |
Why?
|
| Breast | 2 | 2012 | 1969 | 0.060 |
Why?
|
| Muscle, Skeletal | 2 | 2018 | 4931 | 0.060 |
Why?
|
| Endometrial Neoplasms | 1 | 2014 | 1353 | 0.060 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2011 | 852 | 0.060 |
Why?
|
| Cyclin D1 | 1 | 2006 | 463 | 0.060 |
Why?
|
| Genotype | 4 | 2007 | 12951 | 0.060 |
Why?
|
| Multigene Family | 3 | 2010 | 1102 | 0.060 |
Why?
|
| Endometrium | 1 | 2007 | 424 | 0.060 |
Why?
|
| Macrophages | 3 | 2022 | 5655 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2010 | 987 | 0.060 |
Why?
|
| Cholesterol | 2 | 2010 | 2917 | 0.060 |
Why?
|
| Sequence Deletion | 2 | 2007 | 1526 | 0.060 |
Why?
|
| Sexual Maturation | 1 | 2006 | 265 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2010 | 3002 | 0.060 |
Why?
|
| Histones | 3 | 2021 | 2599 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 5 | 2007 | 3846 | 0.060 |
Why?
|
| Fasting | 1 | 2010 | 1593 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 18029 | 0.060 |
Why?
|
| Environmental Pollutants | 1 | 2013 | 1179 | 0.060 |
Why?
|
| Organogenesis | 1 | 2005 | 222 | 0.060 |
Why?
|
| Cholesterol, HDL | 1 | 2010 | 1814 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2010 | 1538 | 0.060 |
Why?
|
| Lymphatic Vessels | 1 | 2007 | 353 | 0.060 |
Why?
|
| Cisplatin | 1 | 2009 | 1662 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2015 | 5221 | 0.060 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2727 | 0.050 |
Why?
|
| Lung Neoplasms | 3 | 2015 | 13102 | 0.050 |
Why?
|
| Gene Products, tat | 2 | 1993 | 120 | 0.050 |
Why?
|
| Linkage Disequilibrium | 1 | 2007 | 1997 | 0.050 |
Why?
|
| Ectoderm | 1 | 2022 | 137 | 0.050 |
Why?
|
| Oogenesis | 1 | 2023 | 131 | 0.050 |
Why?
|
| Trophoblasts | 1 | 2004 | 215 | 0.050 |
Why?
|
| Embryonic Development | 1 | 2007 | 711 | 0.050 |
Why?
|
| Cell Division | 2 | 2003 | 4568 | 0.050 |
Why?
|
| Kinetics | 2 | 2004 | 6473 | 0.050 |
Why?
|
| 3T3 Cells | 2 | 2006 | 1101 | 0.050 |
Why?
|
| Osteoblasts | 1 | 2008 | 1166 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 19905 | 0.050 |
Why?
|
| Lysosomes | 1 | 2007 | 893 | 0.050 |
Why?
|
| Respirovirus Infections | 2 | 1999 | 50 | 0.050 |
Why?
|
| B-Lymphocytes | 2 | 2012 | 4665 | 0.050 |
Why?
|
| Virion | 2 | 2001 | 433 | 0.050 |
Why?
|
| Homozygote | 1 | 2006 | 1785 | 0.050 |
Why?
|
| Parathyroid Hormone | 1 | 2008 | 1801 | 0.050 |
Why?
|
| Nucleocapsid Proteins | 1 | 2001 | 77 | 0.050 |
Why?
|
| Adenocarcinoma | 2 | 2015 | 6364 | 0.050 |
Why?
|
| Chemotaxis | 3 | 1998 | 607 | 0.050 |
Why?
|
| Indicator Dilution Techniques | 1 | 2000 | 40 | 0.050 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2014 | 730 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 2 | 2011 | 2088 | 0.050 |
Why?
|
| Spodoptera | 1 | 2000 | 153 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 1998 | 3701 | 0.050 |
Why?
|
| HSC70 Heat-Shock Proteins | 1 | 2000 | 52 | 0.050 |
Why?
|
| Miosis | 1 | 2019 | 7 | 0.050 |
Why?
|
| Neuroblastoma | 1 | 2008 | 1226 | 0.050 |
Why?
|
| HLA-B35 Antigen | 1 | 1999 | 8 | 0.050 |
Why?
|
| Doxorubicin | 1 | 2006 | 2234 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 2 | 2011 | 418 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 2009 | 2085 | 0.040 |
Why?
|
| Genome, Viral | 2 | 2001 | 667 | 0.040 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2000 | 150 | 0.040 |
Why?
|
| Diethylhexyl Phthalate | 1 | 2000 | 81 | 0.040 |
Why?
|
| Mitochondria | 2 | 2017 | 3520 | 0.040 |
Why?
|
| Melanins | 1 | 2001 | 289 | 0.040 |
Why?
|
| Ovum | 1 | 2000 | 189 | 0.040 |
Why?
|
| Aldehyde Oxidase | 1 | 2018 | 4 | 0.040 |
Why?
|
| Lymphoma | 1 | 2008 | 1877 | 0.040 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2019 | 70 | 0.040 |
Why?
|
| Fibroblasts | 3 | 2019 | 4161 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2019 | 25625 | 0.040 |
Why?
|
| U937 Cells | 1 | 1999 | 268 | 0.040 |
Why?
|
| Peptides | 1 | 2011 | 4409 | 0.040 |
Why?
|
| Measles virus | 1 | 1998 | 68 | 0.040 |
Why?
|
| Gastrulation | 1 | 2018 | 32 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2008 | 2455 | 0.040 |
Why?
|
| Weaning | 1 | 2018 | 105 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2009 | 5974 | 0.040 |
Why?
|
| Ligands | 2 | 2003 | 3282 | 0.040 |
Why?
|
| Staining and Labeling | 2 | 2017 | 1100 | 0.040 |
Why?
|
| TATA Box | 1 | 1998 | 128 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2002 | 1950 | 0.040 |
Why?
|
| Viral Matrix Proteins | 2 | 1990 | 186 | 0.040 |
Why?
|
| Heterosexuality | 1 | 2000 | 276 | 0.040 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2008 | 2043 | 0.040 |
Why?
|
| MyoD Protein | 1 | 2018 | 151 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2022 | 1572 | 0.040 |
Why?
|
| Chemotactic Factors | 1 | 1998 | 199 | 0.040 |
Why?
|
| Allantois | 1 | 1997 | 33 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 17446 | 0.040 |
Why?
|
| Succinimides | 1 | 2017 | 79 | 0.040 |
Why?
|
| Benzamides | 2 | 2015 | 1379 | 0.040 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1999 | 442 | 0.040 |
Why?
|
| Time Factors | 7 | 2022 | 40075 | 0.040 |
Why?
|
| Mutagenesis | 4 | 2006 | 1266 | 0.040 |
Why?
|
| Chorion | 1 | 1997 | 117 | 0.040 |
Why?
|
| Fluoresceins | 1 | 2017 | 235 | 0.040 |
Why?
|
| Genes, fos | 1 | 1997 | 183 | 0.040 |
Why?
|
| Mice, Inbred ICR | 3 | 2007 | 352 | 0.040 |
Why?
|
| Hemophilia A | 1 | 2000 | 351 | 0.040 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2019 | 320 | 0.040 |
Why?
|
| E2F Transcription Factors | 1 | 2017 | 277 | 0.040 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 1997 | 143 | 0.040 |
Why?
|
| Microscopy, Video | 1 | 1997 | 245 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2017 | 170 | 0.040 |
Why?
|
| Reference Values | 2 | 2006 | 4982 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 5256 | 0.040 |
Why?
|
| Models, Genetic | 2 | 2013 | 3494 | 0.040 |
Why?
|
| Chromosomal Instability | 1 | 2017 | 184 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2019 | 611 | 0.030 |
Why?
|
| Genes, env | 2 | 1998 | 95 | 0.030 |
Why?
|
| Abdominal Neoplasms | 1 | 2018 | 292 | 0.030 |
Why?
|
| Culture Media | 1 | 1998 | 908 | 0.030 |
Why?
|
| Dinoprostone | 1 | 2019 | 600 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1998 | 599 | 0.030 |
Why?
|
| Membrane Fusion | 1 | 1998 | 273 | 0.030 |
Why?
|
| Carcinogens | 1 | 1998 | 466 | 0.030 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 1996 | 177 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 4751 | 0.030 |
Why?
|
| HIV-2 | 1 | 1996 | 167 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2008 | 2942 | 0.030 |
Why?
|
| Viral Nonstructural Proteins | 1 | 1997 | 241 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 1997 | 898 | 0.030 |
Why?
|
| Cluster Analysis | 2 | 2013 | 2715 | 0.030 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2016 | 154 | 0.030 |
Why?
|
| Xenopus Proteins | 1 | 2018 | 433 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2018 | 1150 | 0.030 |
Why?
|
| Tretinoin | 1 | 2018 | 517 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 3462 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 2 | 2005 | 2007 | 0.030 |
Why?
|
| Karyotyping | 1 | 2017 | 1243 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2017 | 351 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2007 | 4456 | 0.030 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 1994 | 57 | 0.030 |
Why?
|
| Lactation | 1 | 2017 | 412 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2016 | 399 | 0.030 |
Why?
|
| Osteonectin | 1 | 2014 | 34 | 0.030 |
Why?
|
| Interleukin-18 | 1 | 2016 | 249 | 0.030 |
Why?
|
| LLC-PK1 Cells | 1 | 1994 | 132 | 0.030 |
Why?
|
| Lactalbumin | 1 | 2014 | 21 | 0.030 |
Why?
|
| gamma Catenin | 1 | 2014 | 44 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 1998 | 1202 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2007 | 3479 | 0.030 |
Why?
|
| Organ Specificity | 2 | 2011 | 2008 | 0.030 |
Why?
|
| Sodium-Glucose Transporter 1 | 1 | 1994 | 112 | 0.030 |
Why?
|
| Neurons | 2 | 2011 | 9338 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2000 | 1200 | 0.030 |
Why?
|
| Oxygen | 1 | 2006 | 4189 | 0.030 |
Why?
|
| Cycloheximide | 1 | 1994 | 347 | 0.030 |
Why?
|
| Dactinomycin | 1 | 1994 | 318 | 0.030 |
Why?
|
| gamma-Glutamyltransferase | 1 | 1994 | 134 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 1997 | 1420 | 0.030 |
Why?
|
| Epitopes | 2 | 1999 | 2571 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1994 | 377 | 0.030 |
Why?
|
| Tumor Burden | 2 | 2011 | 1915 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2000 | 1463 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 2 | 2001 | 2699 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2000 | 4011 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 2 | 2014 | 1799 | 0.030 |
Why?
|
| Monocytes | 2 | 2022 | 2596 | 0.030 |
Why?
|
| HIV Antigens | 1 | 1994 | 347 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2014 | 196 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2016 | 707 | 0.030 |
Why?
|
| Restriction Mapping | 2 | 1991 | 878 | 0.030 |
Why?
|
| Troponin C | 1 | 2013 | 25 | 0.030 |
Why?
|
| HeLa Cells | 3 | 2010 | 3128 | 0.030 |
Why?
|
| Adjuvants, Immunologic | 1 | 1998 | 1000 | 0.030 |
Why?
|
| Cell Nucleus | 2 | 2013 | 2969 | 0.030 |
Why?
|
| Isoquinolines | 1 | 1994 | 367 | 0.030 |
Why?
|
| DNA Restriction Enzymes | 4 | 1987 | 570 | 0.030 |
Why?
|
| Cysteine | 1 | 1997 | 874 | 0.030 |
Why?
|
| Focal Adhesions | 1 | 2013 | 121 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2009 | 4838 | 0.030 |
Why?
|
| 5' Untranslated Regions | 1 | 2013 | 249 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2018 | 1117 | 0.030 |
Why?
|
| Amphibians | 1 | 2012 | 30 | 0.030 |
Why?
|
| Atrazine | 1 | 2012 | 9 | 0.030 |
Why?
|
| Glutathione Transferase | 2 | 2007 | 595 | 0.030 |
Why?
|
| Genes, tat | 1 | 1991 | 15 | 0.030 |
Why?
|
| Recombination, Genetic | 2 | 1994 | 1586 | 0.030 |
Why?
|
| Sexual Development | 1 | 2012 | 34 | 0.030 |
Why?
|
| Dihydrotestosterone | 1 | 2012 | 190 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1999 | 1821 | 0.030 |
Why?
|
| Animals, Wild | 1 | 2012 | 90 | 0.030 |
Why?
|
| Evolution, Molecular | 2 | 1997 | 1940 | 0.030 |
Why?
|
| Cytoplasm | 2 | 2011 | 1539 | 0.030 |
Why?
|
| Genetic Engineering | 1 | 1997 | 951 | 0.030 |
Why?
|
| HN Protein | 2 | 1988 | 8 | 0.030 |
Why?
|
| Recombinant Proteins | 5 | 2000 | 6622 | 0.020 |
Why?
|
| Neoplasms | 2 | 2012 | 21683 | 0.020 |
Why?
|
| Herbicides | 1 | 2012 | 100 | 0.020 |
Why?
|
| Dioxins | 1 | 2012 | 102 | 0.020 |
Why?
|
| Dexamethasone | 1 | 1998 | 1951 | 0.020 |
Why?
|
| Simian immunodeficiency virus | 1 | 1996 | 846 | 0.020 |
Why?
|
| Cattle | 4 | 1995 | 3922 | 0.020 |
Why?
|
| SSPE Virus | 1 | 1990 | 3 | 0.020 |
Why?
|
| Spermatogenesis | 1 | 2012 | 262 | 0.020 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2013 | 375 | 0.020 |
Why?
|
| Naphthols | 1 | 2010 | 45 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2015 | 907 | 0.020 |
Why?
|
| Structure-Activity Relationship | 2 | 2000 | 3129 | 0.020 |
Why?
|
| Twins | 1 | 2012 | 339 | 0.020 |
Why?
|
| Nitriles | 1 | 2015 | 956 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2014 | 1901 | 0.020 |
Why?
|
| S-Adenosylmethionine | 1 | 2011 | 212 | 0.020 |
Why?
|
| Culture | 1 | 2014 | 633 | 0.020 |
Why?
|
| Cadherins | 1 | 2015 | 907 | 0.020 |
Why?
|
| High Mobility Group Proteins | 1 | 2010 | 187 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 2 | 2001 | 913 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 890 | 0.020 |
Why?
|
| Precipitin Tests | 2 | 2001 | 829 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2015 | 1276 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 11524 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 940 | 0.020 |
Why?
|
| Phosphatidylcholines | 1 | 2011 | 411 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2015 | 713 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2011 | 212 | 0.020 |
Why?
|
| Vaccinia virus | 1 | 1991 | 349 | 0.020 |
Why?
|
| Actins | 1 | 1997 | 2121 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2011 | 500 | 0.020 |
Why?
|
| Autophagy | 1 | 2017 | 1300 | 0.020 |
Why?
|
| Sodium | 1 | 1994 | 1623 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 2942 | 0.020 |
Why?
|
| Microfluidics | 1 | 2014 | 662 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 1997 | 2382 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2016 | 2513 | 0.020 |
Why?
|
| Protein Stability | 1 | 2010 | 557 | 0.020 |
Why?
|
| Government Regulation | 1 | 2013 | 522 | 0.020 |
Why?
|
| Spleen | 1 | 1994 | 2362 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2016 | 2751 | 0.020 |
Why?
|
| Proteome | 1 | 2018 | 1799 | 0.020 |
Why?
|
| Quinazolines | 1 | 2015 | 1356 | 0.020 |
Why?
|
| Regeneration | 1 | 2017 | 1485 | 0.020 |
Why?
|
| Prognosis | 3 | 2010 | 29063 | 0.020 |
Why?
|
| Environment | 1 | 2014 | 1124 | 0.020 |
Why?
|
| Niacinamide | 1 | 2010 | 417 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2010 | 513 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2014 | 1157 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2000 | 4217 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 1434 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2010 | 433 | 0.020 |
Why?
|
| Sex Factors | 1 | 2022 | 10397 | 0.020 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2007 | 69 | 0.020 |
Why?
|
| Viral Core Proteins | 1 | 1988 | 162 | 0.020 |
Why?
|
| Hemagglutinins, Viral | 1 | 1987 | 67 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2014 | 2373 | 0.020 |
Why?
|
| Sirtuins | 1 | 2010 | 323 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 1085 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1998 | 2752 | 0.020 |
Why?
|
| Cytogenetic Analysis | 1 | 2008 | 295 | 0.020 |
Why?
|
| Embryonic Induction | 1 | 2007 | 149 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2011 | 6386 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 480 | 0.020 |
Why?
|
| Lymphocytes | 1 | 1994 | 2617 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2011 | 1792 | 0.020 |
Why?
|
| Endocrinology | 1 | 2013 | 443 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2008 | 489 | 0.020 |
Why?
|
| Boronic Acids | 1 | 2011 | 965 | 0.020 |
Why?
|
| Phosphoproteins | 2 | 1998 | 2440 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2006 | 279 | 0.020 |
Why?
|
| Age of Onset | 1 | 2013 | 3271 | 0.020 |
Why?
|
| Jurkat Cells | 2 | 1998 | 743 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2018 | 2872 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2008 | 8436 | 0.020 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2007 | 144 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2007 | 464 | 0.020 |
Why?
|
| Antibodies | 1 | 2014 | 2460 | 0.020 |
Why?
|
| Yeasts | 1 | 2007 | 285 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 1998 | 2987 | 0.020 |
Why?
|
| Proteins | 2 | 2012 | 6103 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2017 | 3279 | 0.020 |
Why?
|
| Response Elements | 1 | 2007 | 312 | 0.020 |
Why?
|
| Trypsin | 1 | 2006 | 511 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 1998 | 4149 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2016 | 2575 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2011 | 1144 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2006 | 547 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2008 | 491 | 0.020 |
Why?
|
| Mice, Knockout | 3 | 2007 | 14557 | 0.020 |
Why?
|
| Capsid | 1 | 1988 | 436 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 1997 | 2541 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 1997 | 5097 | 0.020 |
Why?
|
| Thyroid Gland | 1 | 2012 | 1173 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2010 | 1060 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 2171 | 0.020 |
Why?
|
| Pyrazines | 1 | 2011 | 1230 | 0.020 |
Why?
|
| Skin | 1 | 1998 | 4364 | 0.020 |
Why?
|
| DNA, Recombinant | 2 | 1997 | 476 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 2938 | 0.020 |
Why?
|
| Haplorhini | 2 | 1998 | 552 | 0.020 |
Why?
|
| Virulence | 2 | 1998 | 1333 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2015 | 4026 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2007 | 893 | 0.010 |
Why?
|
| Piperazines | 1 | 1994 | 2488 | 0.010 |
Why?
|
| Inclusion Bodies, Viral | 1 | 1983 | 45 | 0.010 |
Why?
|
| Rats | 2 | 2014 | 24260 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2008 | 1472 | 0.010 |
Why?
|
| Astrocytes | 1 | 2011 | 1270 | 0.010 |
Why?
|
| HIV | 1 | 1991 | 1604 | 0.010 |
Why?
|
| Myocardium | 1 | 1997 | 4776 | 0.010 |
Why?
|
| Gene Amplification | 1 | 2008 | 1063 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2006 | 1185 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 2004 | 242 | 0.010 |
Why?
|
| Pyridones | 1 | 2008 | 712 | 0.010 |
Why?
|
| Progesterone | 1 | 2007 | 776 | 0.010 |
Why?
|
| Recurrence | 1 | 2015 | 8340 | 0.010 |
Why?
|
| Young Adult | 2 | 2021 | 56430 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2015 | 4554 | 0.010 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2004 | 211 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2008 | 1375 | 0.010 |
Why?
|
| Glucose | 1 | 1994 | 4397 | 0.010 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 2 | 1993 | 127 | 0.010 |
Why?
|
| Cell Fusion | 2 | 1998 | 297 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2008 | 1420 | 0.010 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2001 | 53 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1997 | 1723 | 0.010 |
Why?
|
| Inflammation | 1 | 2022 | 10638 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2008 | 2649 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1997 | 4253 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2010 | 4204 | 0.010 |
Why?
|
| Monophenol Monooxygenase | 1 | 2001 | 69 | 0.010 |
Why?
|
| Mice, Transgenic | 2 | 2006 | 9734 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2013 | 3703 | 0.010 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2001 | 109 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 2 | 1998 | 1836 | 0.010 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2000 | 58 | 0.010 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2000 | 114 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2017 | 40561 | 0.010 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2008 | 1660 | 0.010 |
Why?
|
| HIV Seropositivity | 2 | 1998 | 971 | 0.010 |
Why?
|
| Viscera | 1 | 2000 | 139 | 0.010 |
Why?
|
| Lung | 2 | 2015 | 9856 | 0.010 |
Why?
|
| STAT1 Transcription Factor | 1 | 2001 | 320 | 0.010 |
Why?
|
| Endoderm | 1 | 2000 | 154 | 0.010 |
Why?
|
| Histone Acetyltransferases | 1 | 2001 | 336 | 0.010 |
Why?
|
| beta Catenin | 1 | 2005 | 1059 | 0.010 |
Why?
|
| Solutions | 1 | 2000 | 426 | 0.010 |
Why?
|
| Databases as Topic | 1 | 2001 | 475 | 0.010 |
Why?
|
| Smad2 Protein | 1 | 2000 | 156 | 0.010 |
Why?
|
| Models, Biological | 2 | 2011 | 9583 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2009 | 2635 | 0.010 |
Why?
|
| Dimerization | 1 | 2001 | 893 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2005 | 1364 | 0.010 |
Why?
|
| Nevus | 1 | 2001 | 204 | 0.010 |
Why?
|
| Homeostasis | 1 | 2010 | 3340 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2007 | 2263 | 0.010 |
Why?
|
| Lipids | 1 | 2010 | 3305 | 0.010 |
Why?
|
| Gene Library | 1 | 2001 | 1074 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1998 | 326 | 0.010 |
Why?
|
| Decision Making | 1 | 2013 | 3887 | 0.010 |
Why?
|
| Callithrix | 1 | 1998 | 93 | 0.010 |
Why?
|
| Proline | 1 | 2000 | 458 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2000 | 936 | 0.010 |
Why?
|
| Adult | 4 | 2021 | 214055 | 0.010 |
Why?
|
| Vero Cells | 1 | 1998 | 485 | 0.010 |
Why?
|
| Interferons | 1 | 2001 | 706 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2001 | 2327 | 0.010 |
Why?
|
| Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 1 | 1996 | 22 | 0.010 |
Why?
|
| 1-Deoxynojirimycin | 1 | 1996 | 18 | 0.010 |
Why?
|
| Stem Cells | 1 | 2010 | 3567 | 0.010 |
Why?
|
| Microbiological Techniques | 1 | 1998 | 102 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2001 | 1730 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 1997 | 216 | 0.010 |
Why?
|
| Swine | 1 | 2007 | 5917 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2000 | 794 | 0.010 |
Why?
|
| Genome, Human | 1 | 2010 | 4420 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2007 | 2915 | 0.010 |
Why?
|
| Glycoside Hydrolases | 1 | 1996 | 133 | 0.010 |
Why?
|
| Macaca fascicularis | 1 | 1998 | 915 | 0.010 |
Why?
|
| RNA Editing | 1 | 1997 | 148 | 0.010 |
Why?
|
| Integration Host Factors | 1 | 1995 | 13 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2000 | 2011 | 0.010 |
Why?
|
| Virus Latency | 1 | 1997 | 358 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 1997 | 655 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 1999 | 1791 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 1998 | 810 | 0.010 |
Why?
|
| Liver | 1 | 2010 | 7474 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1987 | 1375 | 0.010 |
Why?
|
| HIV Long Terminal Repeat | 1 | 1993 | 88 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1998 | 970 | 0.010 |
Why?
|
| Th1 Cells | 1 | 1998 | 1057 | 0.010 |
Why?
|
| Th2 Cells | 1 | 1998 | 1061 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1997 | 1224 | 0.010 |
Why?
|
| Avian Sarcoma Viruses | 1 | 1991 | 84 | 0.010 |
Why?
|
| Diet | 1 | 2010 | 7939 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 1998 | 1312 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2013 | 23338 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2000 | 5456 | 0.010 |
Why?
|
| Virus Integration | 1 | 1991 | 299 | 0.010 |
Why?
|
| Colon | 1 | 1997 | 1772 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 1997 | 3036 | 0.000 |
Why?
|
| Enzyme Inhibitors | 1 | 1996 | 3798 | 0.000 |
Why?
|
| Rabbits | 1 | 1991 | 4894 | 0.000 |
Why?
|
| Hemagglutination, Viral | 1 | 1983 | 12 | 0.000 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 1983 | 156 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 2 | 1991 | 9274 | 0.000 |
Why?
|
| Adsorption | 1 | 1983 | 201 | 0.000 |
Why?
|
| Anti-HIV Agents | 1 | 1998 | 4256 | 0.000 |
Why?
|
| Child | 1 | 1998 | 77709 | 0.000 |
Why?
|
| Adolescent | 1 | 1998 | 85781 | 0.000 |
Why?
|
| Middle Aged | 1 | 1998 | 213383 | 0.000 |
Why?
|